FindTrial
Sign In

JKB-122

DRUG2 trials

Sponsors

TaiwanJ Pharmaceuticals Co., Ltd

Conditions

Autoimmune Hepatitis

Phase 2

Liver Test Study of Using JKB-122 in Autoimmune Hepatitis (AIH) Patients Who Are Refractory or Intolerant to Current Therapies
CompletedNCT02556372
TaiwanJ Pharmaceuticals Co., LtdAutoimmune Hepatitis
Start: 2016-04-30End: 2019-01-21Updated: 2020-07-21
Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)
NCT04371718
TaiwanJ Pharmaceuticals Co., LtdAutoimmune Hepatitis
Start: 2020-11-30End: 2024-02-29Target: 120Updated: 2020-09-01

Related Papers

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.
2022-12-137 citations